n. an *antiplatelet drug given to prevent strokes or heart attacks in those at risk. Side-effects may include gastrointestinal bleeding.
any one of a class of drugs that reduce platelet aggregation (see platelet activation) and therefore the formation of clot (see thrombosis). Examples are *abciximab, *aspirin, *clopidogrel, prasugrel, and ticagrelor.... antiplatelet drug
(DAPT) aspirin prescribed at the same time as another oral *antiplatelet drug (e.g. clopidogrel, prasugrel, ticagrelor) for patients deemed to be at temporarily increased risk of coronary or stent thrombosis (typically following *acute coronary syndrome or new coronary stent implantation). After a prespecified time (usually 12 months), the aspirin is continued and the other antiplatelet drug is stopped.... dual antiplatelet therapy
n. an *anticoagulant present in the salivary glands of *leeches and in certain snake venoms that prevents *blood coagulation by inhibiting the action of the enzyme *thrombin. The anticoagulant bivalirudin is a genetically engineered form of hirudin from the medicinal leech. It is administered by intravenous injection and infusion, in combination with aspirin and clopidogrel, to treat patients with S–T elevation *myocardial infarction who are undergoing primary *percutaneous coronary intervention.... hirudin